Cargando…

P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

Detalles Bibliográficos
Autores principales: Piccione, E. C., Belousov, A., Hamidi, H., Carlo-Stella, C., Dickinson, M., Morschhauser, F., Lundberg, L., Humphrey, K., Tracy, S., Hutchings, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431351/
http://dx.doi.org/10.1097/01.HS9.0000847704.12245.1f
_version_ 1784780030839095296
author Piccione, E. C.
Belousov, A.
Hamidi, H.
Carlo-Stella, C.
Dickinson, M.
Morschhauser, F.
Lundberg, L.
Humphrey, K.
Tracy, S.
Hutchings, M.
author_facet Piccione, E. C.
Belousov, A.
Hamidi, H.
Carlo-Stella, C.
Dickinson, M.
Morschhauser, F.
Lundberg, L.
Humphrey, K.
Tracy, S.
Hutchings, M.
author_sort Piccione, E. C.
collection PubMed
description
format Online
Article
Text
id pubmed-9431351
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313512022-08-31 P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) Piccione, E. C. Belousov, A. Hamidi, H. Carlo-Stella, C. Dickinson, M. Morschhauser, F. Lundberg, L. Humphrey, K. Tracy, S. Hutchings, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431351/ http://dx.doi.org/10.1097/01.HS9.0000847704.12245.1f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Piccione, E. C.
Belousov, A.
Hamidi, H.
Carlo-Stella, C.
Dickinson, M.
Morschhauser, F.
Lundberg, L.
Humphrey, K.
Tracy, S.
Hutchings, M.
P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_full P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_fullStr P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_full_unstemmed P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_short P1210: IMMUNE CORRELATES OF RESPONSE TO GLOFITAMAB: BIOMARKER FINDINGS FROM A PIVOTAL PHASE II EXPANSION STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
title_sort p1210: immune correlates of response to glofitamab: biomarker findings from a pivotal phase ii expansion study in patients with relapsed or refractory (r/r) diffuse large b-cell lymphoma (dlbcl)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431351/
http://dx.doi.org/10.1097/01.HS9.0000847704.12245.1f
work_keys_str_mv AT piccioneec p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT belousova p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT hamidih p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT carlostellac p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT dickinsonm p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT morschhauserf p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT lundbergl p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT humphreyk p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT tracys p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl
AT hutchingsm p1210immunecorrelatesofresponsetoglofitamabbiomarkerfindingsfromapivotalphaseiiexpansionstudyinpatientswithrelapsedorrefractoryrrdiffuselargebcelllymphomadlbcl